To corroborate our hypothesis that CD69 is an ideal imaging agent for monitoring ICI response by virtue of early T-cell activation, we measured CD69 expression on T cells following activation in vitro and on GL261 glioma cells. This evidence concerns the gene CD69 and central nervous system cancer.